MedTrace Logo

Natural Killer (NK) Cells Following Bariatric Surgery

NCT02732535 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2016-04-14

No results posted yet for this study

Summary

This study will determine the role of the NK cells before and after bariatric surgery. The investigators selected patients with NAFLD.

A Fibroscan evaluation will be assessed as a new modality to evaluate liver fibrosis.

Conditions

  • Natural Killer Cell Deficiency, Familial Isolated

Interventions

PROCEDURE

sleeve gastrectomy , roux-en-y gastric bypass

laparoscopic sleeve gastrectomy or laparoscopic gastric bypass

Sponsors & Collaborators

  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • Abed Khalaileh, MD, PhD · israel ministrty of health

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2017-08-31
Completion
2017-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02732535 on ClinicalTrials.gov